Abstract: This article is a critical analysis of a study, "Minimally Manipulated Bone Marrow Concentrate Compared with Microfracture Treatment of Full-Thickness Chondral Defects: A One-Year Study in an Equine Model," by Chu et al. (. 100(2):138-146, 2018). The investigation compared two interventions in the management of full-thickness chondral defects in an equine model: autologous bone marrow concentrate without concomitant microfracture treatment versus microfracture treatment alone. This review analyzes the methodology and results of their investigation and examines how their findings may influence the continued development of therapeutic options for full-thickness cartilage injuries. The study utilized in vitro analysis, arthroscopic assessment, magnetic resonance imaging (MRI) evaluation, and histological analysis to compare the treatments and their influence on the quality of cartilage repair. Although Chu et al. reported similar results between groups, their findings offer insight into the role of arthroscopy, MRI, and histology in the evaluation of repair quality. We compare their findings to those of similar investigations, highlighting the limited therapeutic options and variable clinical outcomes related to the treatment of full-thickness articular cartilage defects.
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
This study is a critical look into the treatment options for full-thickness cartilage injuries, specifically looking at bone marrow concentrates and microfracture treatment.
Research Overview
The research is an analysis of a study by Chu et al. which tested two treatment methods for full-thickness chondral defects in horses.
The treatment methods were autologous bone marrow concentrate, which is a patient’s own bone marrow, without additional microfracture treatment versus microfracture treatment alone.
Research Methodology
The research used various ways to compare the quality of cartilage repair between the two treatment options, including in vitro analysis, arthroscopic assessment, MRI evaluation, and histological analysis.
Research Findings
The study found similar results between both treatment groups; Chu et al.’s findings shed light on the importance of arthroscopy, MRI, and histology in assessing the quality of repair in cartilage injuries.
This analysis is then compared with findings from comparable investigations. These comparisons highlight the limited therapeutic options and the varying clinical outcomes in relation to the treatment of full-thickness articular cartilage defects.
Implications of the Study
Although the study did not heavily favor one treatment over the other, its findings and methods may influence the development of other therapeutic options for full-thickness cartilage injuries in the future.
Additionally, the study also emphasized the importance of using multiple assessment methods (viz., arthroscopy, MRI, and histology) for a more comprehensive and accurate evaluation of treatment outcomes.
Cite This Article
APA
Apostolakos JM, Lazaro L, Williams RJ.
(2018).
The Use of Bone Marrow Concentrate in the Treatment of Full-Thickness Chondral Defects.
HSS J, 15(1), 96-99.
https://doi.org/10.1007/s11420-018-9647-z
Department of Orthopaedic Surgery, Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021 USA.
Lazaro, Lionel
Department of Orthopaedic Surgery, Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021 USA.
Williams, Riley J
Department of Orthopaedic Surgery, Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021 USA.
Conflict of Interest Statement
John M. Apostolakos, MD, MPH, and Lionel Lazaro, MD, declare that they have no conflicts of interest. Riley J. Williams, MD, reports receiving intellectual property royalties from and being a paid consultant to Arthrex, Inc.; owning stock or stock options in Cymedica, Inc., Pristine Surgical, R2T2 Laboratories, Inc., and RecoverX; receiving research support from Histogenics, Inc.; being a paid consultant to JRF Ortho and an unpaid consultant to R2T2 Laboratories, Inc.; and receiving publishing royalties from Springer.N/AN/ADisclosure forms provided by the authors are available with the online version of this article.
References
This article includes 27 references
Bae DK, Yoon KH, Song SJ. Cartilage healing after microfracture in osteoarthritic knees.. Arthroscopy 2006 Apr;22(4):367-74.
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.. Cytotherapy 2006;8(4):315-7.
Gobbi A, Whyte GP. One-Stage Cartilage Repair Using a Hyaluronic Acid-Based Scaffold With Activated Bone Marrow-Derived Mesenchymal Stem Cells Compared With Microfracture: Five-Year Follow-up.. Am J Sports Med 2016 Nov;44(11):2846-2854.
Gobbi A, Karnatzikos G, Sankineani SR. One-step surgery with multipotent stem cells for the treatment of large full-thickness chondral defects of the knee.. Am J Sports Med 2014 Mar;42(3):648-57.
Kim HK, Moran ME, Salter RB. The potential for regeneration of articular cartilage in defects created by chondral shaving and subchondral abrasion. An experimental investigation in rabbits.. J Bone Joint Surg Am 1991 Oct;73(9):1301-15.
Kreuz PC, Erggelet C, Steinwachs MR, Krause SJ, Lahm A, Niemeyer P, Ghanem N, Uhl M, Südkamp N. Is microfracture of chondral defects in the knee associated with different results in patients aged 40 years or younger?. Arthroscopy 2006 Nov;22(11):1180-6.
Kreuz PC, Steinwachs MR, Erggelet C, Krause SJ, Konrad G, Uhl M, Südkamp N. Results after microfracture of full-thickness chondral defects in different compartments in the knee.. Osteoarthritis Cartilage 2006 Nov;14(11):1119-25.
Madry H, Orth P, Cucchiarini M. Role of the Subchondral Bone in Articular Cartilage Degeneration and Repair.. J Am Acad Orthop Surg 2016 Apr;24(4):e45-6.
Magnussen RA, Dunn WR, Carey JL, Spindler KP. Treatment of focal articular cartilage defects in the knee: a systematic review.. Clin Orthop Relat Res 2008 Apr;466(4):952-62.
Minas T, Gomoll AH, Rosenberger R, Royce RO, Bryant T. Increased failure rate of autologous chondrocyte implantation after previous treatment with marrow stimulation techniques.. Am J Sports Med 2009 May;37(5):902-8.
Mithoefer K, Williams RJ 3rd, Warren RF, Potter HG, Spock CR, Jones EC, Wickiewicz TL, Marx RG. The microfracture technique for the treatment of articular cartilage lesions in the knee. A prospective cohort study.. J Bone Joint Surg Am 2005 Sep;87(9):1911-20.
Mithoefer K, Venugopal V, Manaqibwala M. Incidence, Degree, and Clinical Effect of Subchondral Bone Overgrowth After Microfracture in the Knee.. Am J Sports Med 2016 Aug;44(8):2057-63.
Shapiro F, Koide S, Glimcher MJ. Cell origin and differentiation in the repair of full-thickness defects of articular cartilage.. J Bone Joint Surg Am 1993 Apr;75(4):532-53.
Squires GR, Okouneff S, Ionescu M, Poole AR. The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis.. Arthritis Rheum 2003 May;48(5):1261-70.